Vinorelbine (Navelbine®) in the treatment of non-small-cell lung cancer: Recent developments in combination chemotherapy and radiotherapy

Annals of Oncology

Volumn 10, Issue SUPPL. 5, 1999, Pages

  Gralla, R ^a   Harper, P ^c   Johnson, S ^c   Delgado, F M ^b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c NONE

Author keywords

Cisplatin non small cell lung cancer; Neo adjuvant; Radiotherapy; Vinorelbine

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; IFOSFAMIDE; MITOMYCIN C; NAVELBINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONFERENCE PAPER; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; VINBLASTINE;

EID: 0032692746     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_5.S47     Document Type: Conference Paper

References (42)

1. Jacoulet P, Breton JL, Westeel V et al. Phase I study of vinorelbine and carboplatin in advanced non-small-cell lung cancer. Lung Cancer 1995; 12: 247-57.
2. Crawford I, O'Rourke MA. Vinorelbine (vinorelbine®)-carboplatin combination therapy: Dose intensification with granulocyte colony-stimulating factor. Semin Oncol 1994; 21 (Suppl 10): 73-8.
3. Masotti A, Borzellino G, Zannini G et al. Efficacy and toxicity of vinorelbine carboplatin combination in the treatment of advanced adenocarcinoma or large-cell carcinoma of the lung. Tumori 1995; 81: 112-6.
4. Parente B, Barata F, Moura SAJ et al. Chemotherapy with vinorelbine + carboplatin in advanced non-small-cell lung cancer. Lung Cancer 1997; 18 (Suppl 1): A109.
5. Pronzato P, Ghio E, Losardo PL et al. Carboplatin and vinorelbine in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 1996; 37: 610-2.
6. Morere JF, Brunet A, Duran A et al. Ifosfamide and vinorelbine in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1994; 13: A1149.
7. Pawel JV, Schröder M, Grote-Kiehn J et al. Ifosfamide + vinorelbine as treatment for advanced non operable non-small-cell lung cancer. Proc IASLC 1994; 11 (Suppl 1): 116 (Abstr 444).
8. Sparrow C, Brocatto N, Savulski C. Phase II study: Vinorelbine® + ifosfamide in stage IIIB-IV non-small-cell lung cancer. Ann Oncol 1994; 5 (Suppl 8): 158 (Abstr 793).
9. Vallejo C, Romera A, Perez J et al. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small-cell lung carcinoma. Am J Clin Oncol 1996; 19: 584-8.
10. Masters GA, Hoffman PC, Hsieh AL et al. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. J Clin Oncol 1997; 15: 884-92.
11. Gebbia V, Galetta D, Majello E et al. Treatment of stage III-IV non-small-cell lung carcinoma with vinorelbine in combination with Ifosfamide plus MESNA: A study by the Southern Itay Oncology Group (GOIM). Am J Clin Oncol 1996; 19: 278-80.
12. Milleron B, Brambilla C, Blanchon F et al. Phase II study of combination of vinorelbine and mitomycin C in non-small-cell lung cancer. In Solal P (ed): Vinorelbine (Vinorelbine). Update and New Trends. Celigny: John Libbey Eurotext 1991; 151-5.
13. Gralla JR, Kardinal CG, Clark RA et al. Enhancing the safety, efficacy and dose intensity of vinorelbine in combination chemotherapy regimens. Proc Am Soc Clin Oncol 1993; 12: A1122.
14. Lorusso V, Carpagnano F, Di Rienzo G et al. Combination of gemcitabine and vinorelbine in non-small-cell lung cancer. A phase I-II study. Proc Am Soc Clin Oncol 1997; 16: A1628.
15. Lilenbaum RC, Schwartz MA, Cano R et al. Gemcitabine and vinorelbine in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1998; 17: A1901.
16. Vaylet F, L'Her P Merrer J et al. Squamous cell bronchial carcinoma. A study of 31 patients treated with mitomycin C, cisplatin and vinorelbine: Feasibility and effectiveness. Proc Am Soc Clin Oncol 1995; 14: A1136.
17. Perol M, Guerin JC, Cleisbauer JP et al. Multicenter randomized trial comparing cisplatin-mitomycin-vindesine vs. cisplatin-mitomycin-vinorelbine in advanced non-small-cell lung cancer (NSCLC). Proc IASLC 1994; 11 (Suppl 1): 114 (Abstr 434).
18. Kawahara M, Furuse K, Nishiwaka Y et al. Randomized study of vinorelbine or vindesine with cisplatin and mitomycin as induction chemotherapy in stage IIB and IV non-small-cell lung cancer. Proc Am Soc Clin Oncol 1998; 17: 467a (Abstr 1796).
19. Souquet PJ, Fournel P, Lombard-Bohas CH et al. Cisplatin, ifosfamide with various dosages of vinorelbine in non resectable non-small-cell lung cancer. Proc Am Soc Clin Oncol 1995; 14: A1127.
20. Baldini E, Tibaldi C, Chella A et al. Combination chemotherapy with vinorelbine, ifosfamide and cisplatin for the treatment of advanced non-small-cell lung cancer. Ann Oncol 1996; 7: 747-9.
21. Tan EH, Ang PT, Wee J, Khoo KS. Vinorelbine, ifosfamide and cisplatin in advanced non-small-cell lung cancer. Lung Cancer 1997; 18 (Suppl 1): A177.
22. Recchia F, De Fillipis S, Lococo A et al. Phase II study of vinorelbine, ifosfamide and carboplatin in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1996; 15: A1101.
23. Richardet E, Lazaris C, Uribe A et al. Phase II study: Vinorelbine® + etoposide + cisplatin in non operable non-small-cell lung cancer. Eur J Cancer 1993; 29A (Suppl 6): S161 (Abstr 888).
24. Marangolo M, Intini C. Vinorelbine (VB) + cisplatin (DDP) + etoposide (E) in the treatment of non operable non-small-cell lung cancer (NSCLC). Eur J Cancer 1993; 29A (Suppl 6): S163 (Abstr 905).
25. Jacoulet P, Depierre A, Garnier G, Dalphin J-C. Study of combined vinorelbine®-cisplatin VP16 in the treatment of non-small-cell lung cancer. In Pierre Fabre Oncologie (ed): Vinorelbine (Vinorelbine). Update and New Trends. Montrouge: John Libbey Eurotext 1991; 171-7.
26. Comella P, Casaretti R, Daponte A et al. Combination of vinorelbine, cisplatin, and etoposide in advanced non-small-cell lung carcinoma: A pilot study. J Chemother 1994; 6: 67-71.
27. Breau JL, Morere J-F, Boaziz C, Israel L. Combination vinorelbine® -cisplatin-etoposide in bronchial adenocarcinomas. In Pierre Fabre Oncologie (ed): Vinorelbine (Vinorelbine). Update and New Trends. Montrouge: John Libbey Eurotext 1991; 179-84.
28. De Cremoux H, Monnet I, Azli N et al. Fluorouracil and folinic acid, vinorelbine and cisplatin in non-small-cell lung cancer: A phase II study. Proc 4th International Congress on AntiCancer Chemotherapy 1993; 82 (Abstr 97).
29. Gralla RJ, Hesketh PJ, Rittenberg CN et al. Preserving dose-intensity in an active regimen in NSCLC with vinorelbine + mitomycin + cisplatin. Proc Am Soc Clin Oncol 1996; 15: A1123.
30. Comella P, Panza N, Frasci G et al. Gemcitabine-cisplatin vinorelbine Combination in advanced non-small-cell lung cancer. A phase II randomized study. Proc 8th International Congress on Anti-Cancer Chemotherapy 1998; 80 (Abstr 34).
31. Edelstein MP, Wolfe LA, Duch DS. Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small-cell lung cancer. Semin Oncol 1996; 23 (Suppl 5): 41-7.
32. Viallet J, Rousseau P, Souhami L et al. A completed phase I II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated thoracic irradiation in inoperable NSCLC. Proc 8th ECCO Eur J Cancer 1995; 31A (Suppl 5): A1083.
33. Baldini E, Tibaldi C, Ricci S et al. Sequential chemo-radiotherapy in stage IIB inoperable NSCLC: Phase II study Proc 5th Int Cong Anti Cancer Chemother 1995; A0497.
34. Felip E, Tibaldi C, Ricci S et al. Cisplatin and vinorelbine followed by radiotherapy in the treatment of stafe IIIB non-small-cell lung cancer patients. Am J Clin Oncol 1997; 20: 404-6.
35. Tan EH, Wee J, Ang PT et al. Phase II trial of combined chemoradiotherapy in patients with unresectable stafe III non-small-cell lung cancer. Lung Cancer 1997; 18 (Suppl 1): A279.
36. Bardet E, Douillard JY, Riviere A et al. Induction of chemotherapy (ICT cisplatin and vinorelbine) followed by a combination of daily irradiation and carboplatin in stage IIIB non-small-cell lung cancer: Final analysis of a phase II trial. Lung Cancer 1997; 18 (Suppl 1): A352.
37. Zatloukal P, Petruzelka L, Zemandva M et al. Vinorelbine plus cisplatin and concurrent radiotherapy in advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1998; 17: A1947.
38. Milosevic D, Vallerand H, Carbonnelle M et al. Vinorelbine mitomycin cisplatin regimen plus concomitant fluorouracil-cisplatin-radiotherapy for locally advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 1995; 14: A1120.
39. Iaffaioli RV, Caponigro F, Tortoriello A et al. Accelerated split course (type B) thoracic radiation therapy plus vinorelbine carboplatin combination chemotherapy in stage III inoperable non-small-cell lung cancer. Eur J Cancer 1996; 32A: 1901-4.
40. Lorusso V, Carpagnano F, Di Rienzo G et al. Patterns of failure in patients affected with non-small-cell lung cancer treated with neo-adjuvant chemotherapy. Lung Cancer 1997; 18 (Suppl 1): A314.
41. Cigolari S, Curcio C, Massimo M et al. Neoadjuvant chemotherapy with vinorelbine plus cisplatin in stage IIIB non-small-cell lung cancer. A phase II trial. Eur J Cancer 1997; 33A: S1091.
42. Bunn PA. The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol 1992; 16: 10-21.